Adjuvant treatment of gastrointestinal stromal tumor: the proof, the pro, and the practice.

Overview:Gastrointestinal stromal tumors (GIST) are rare tumors, but they are the most common mesenchymal tumor of the gastrointestinal tract, driven by mutations in KIT and PDGF. The KIT and PDGF ...